Quick Preview
✔️ Cerebral Vascular Accident — Visual Field Loss & Suppression
68F
Post-stroke (CVA, left parietal)
Hemianopsia and left-eye suppression
Regained fusion after coMra + syntonics
Glaucoma and Optic Neuropathy in High Myopia
(Click to Expand)
Quick Facts
- Patient: 55-year-old female
- Condition: Glaucoma, optic neuropathy, high myopia
- Context: Entered treatment with restricted visual fields and left eye afferent pupil defect. Acuity stable at OD 20/25, OS 20/40.
- Protocol: 8 coMra Delta 905 treatments over 5 days (Eye Protocol), no adjunctive therapies.
- Outcome Highlights: Significant bilateral field expansion, contrast sensitivity improvement, and better nerve conduction OS. Acuity unchanged.
📂 Expand Full Case Details
Case Details
Practitioner Notes:
- Out of town patient in for short stay duration and so do multiple treatments over short period.
- Baseline: OD acuity 20/25, OS 20/40. Contrast sensitivity OD 1.56, OS 1.08. Restricted fields in both eyes. OS afferent pupil defect measured at 0.78 (anything >0.7 considered damaged).
- Treatment: 8 coMra Delta 905 sessions over 5 days (Eye Protocol).
- Results:
- Visual acuity: No change in either eye.
- Contrast sensitivity: OD improved from 1.56 to 1.68 (normal), OS from 1.08 to 1.16.
- Visual fields:
- OD horizontal: 15° → 45°, vertical: 20° → 42°
- OS horizontal: 15° → 37°, vertical: 12° → 32°
- Nerve conduction: OS afferent pupil defect improved from 0.78 to 0.67.
- Patient noticed expanded fields during treatment sessions.
Practitioner Commentary:
“This is encouraging — the afferent pupil defect improvement reflects better nerve conduction, alongside significant field expansion and contrast gains. These are functional changes that improve daily visual awareness.
Patient Outcome:
“Noticed the fields were bigger during the treatments.”
Related science:
- Transcranial laser + magnetic therapy and multi-modal stimulation (laser, electrostimulation, millimeter-wave) consistently expanded fields (n=165 eyes, Egorov 2013; n=443 eyes, Baranov 2016), matching the large field gains reported here.
- Magnet-based regimens improved electrophysiology and blood flow (n=634 eyes, Kamenskikh 2015); small-cohort low-level laser therapy showed VA and IOP benefits lasting 3 months (n=25 eyes, Kleyman 2016), aligning with contrast and afferent improvements.
✅ Next Steps for Clinicians
📂 Expand For Details
📅 Book a Call
Explore how coMra could fit into your care model Schedule a Conversation →
📄 Download Clinical Brief
Access protocols and objective outcomes
Get the Brief →
💬 Ask a Clinical Question
Get direct answers from our clinical team
Submit Your Question →📨
👉 Return to Eye Main Page